D. Ameti

Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.

S. Glynn, C. Nass, J. Fridey, 1997, The Journal of infectious diseases.

Risk factors for hepatitis C virus infection in United States blood donors

S. Glynn, A. Williams, C. Nass, 2000, Hepatology.

Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort study

E. Murphy, G. Garratty, H. Ownby, 2003, BMC pulmonary medicine.

Low prevalence of flower cells in U.S.A. blood donors infected with human T‐lymphotrophic virus types I and II

G. Schreiber, E. Murphy, N. Luban, 1999, British journal of haematology.

The potential impact of incentives on future blood donation behavior

A. Williams, J. Bethel, G. Schreiber, 2001, Transfusion.

Delayed hypersensitivity skin testing to mumps and Candida albicans antigens is normal in middle-aged HTLV-I- and-II-infected U.S. cohorts.

E. Murphy, D. Wright, G. Nemo, 2001, AIDS research and human retroviruses.

Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: an age-cohort effect for HTLV-II RFLP type aO.

E. Murphy, F. Tekaia, G. de Thé, 1998, Virology.